You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
香港醫思醫療集團(02138.HK)中期收入勁升28.1%至11.18億港元 派中期息15港仙
格隆匯 11-27 12:28

格隆匯11月27日丨香港醫思醫療集團(02138.HK)公佈,截至2019年9月30日止6個月,公司實現總收入11.18億港元,同比增長28.1%;期內溢利2.11億港元,同比增長4.0%;公司權益股東應占溢利1.98億港元,同比增長1.7%;每股基本盈利20.1港仙,宣派中期股息每股15港仙。

於報告期間,醫療服務貢獻的收入由截至2018年9月30日止6個月的1.60億港元上升102.2%至截至2019年9月30日止6個月的3.24億港元。於2019年8月,集團完成收購於香港的兒科服務業務。隨着額外六名兒科及精神科專科註冊醫生加盟集團,於2019年8月,公司亦開始於朗豪坊旗艦店提供兒科服務。

於報告期間,治癒痛症服務貢獻的銷售額為8710萬港元,較截至2018年9月30日止6個月增加40.9%,而截至2016年3月31日止年度,收購前治癒痛症服務貢獻的未經審核總收入為3730萬港元。憑藉多元服務整合策略,集團能夠深化現有客户的額外醫療及養生需求。

於2019年9月30日,包括公司在香港的兩家旗艦店及在中國大陸的七家診所在內,公司共經營56家診所及服務中心,所佔樓面面積合共約28.7萬平方尺,在香港、中國大陸及澳門共有97名全職專屬註冊醫生,涉及19個醫療專科服務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account